The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its patent expiration created a wave of knock-off medications, significantly impacting its position . While specific firms may try to capitalize on male sexual dysfunction, the existing land